Información del producto
- GUSACITINIB
- 1-[5,6-Dihydro-4-[[4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5-oxopyrimido[4,5-d]pyridazin-2-yl]-4-piperidineacetonitrile
- 2-(1-(4-((4-(4-hydroxypiperidin-1-yl)phenyl)amino)-5-oxo-5,6-dihydropyrimido[4,5-d]pyridazin-2-yl)piperidin-4-yl)acetonitrile
- 4-Piperidineacetonitrile, 1-[5,6-dihydro-4-[[4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5-oxopyrimido[4,5-d]pyridazin-2-yl]-
Gusacitinib is a drug that belongs to the class of inhibitor drugs that blocks the activity of Janus kinase (JAK) and has been shown to be effective against alopecia areata, a disease characterized by hair loss. Gusacitinib also inhibits other intracellular targets such as chemoattractant protein and inflammatory lesion. Gusacitinib was developed from a family of compounds that were originally designed for the treatment of cancer. It showed long-term efficacy in inhibiting the growth of cancer cells in mice and clinical studies have shown promising results for its use in treating inflammatory skin diseases.
Propiedades químicas
Consulta técnica sobre: 3D-AHC38160 Gusacitinib
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
